The partners will try out the Ubiquitome Freedom4 hand-held, real-time PCR device in a range of quality assurance applications in food production and distribution.
The NCI aims to fund research projects involving biosamples obtained through the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial.
Genycell will distribute the Sophia Data Driven Medicine platform as part of a package to laboratories and hospitals in Spain and Portugal.
Gene panel testing of cancer patients helps clinicians identify actionable mutations, according to presenters at this year's AACC meeting.
The collaboration is focused on using Biognosys' HRM mass spec technology to facilitate Biodesix's companion diagnostic work.
In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.
Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."
Ivan Oransky discusses the need for reproducibility research at The Conversation.
The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.